SCHEMBL8629576

SCHEMBL8629576

Cc1ncoc1C(O)c1ccccc1F

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 1/20 0.44
CES2 O00748 1/20 0.35
CES1 P23141 1/20 0.35
P2RX7 Q99572 1/20 0.35
HDAC4 P56524 4/20 0.33
HDAC3 O15379 1/20 0.33
HDAC7 Q8WUI4 1/20 0.33
HDAC8 Q9BY41 1/20 0.33
HDAC6 Q9UBN7 1/20 0.33
HDAC9 Q9UKV0 1/20 0.33
HDAC5 Q9UQL6 1/20 0.33
NCOR2 Q9Y618 1/20 0.33
GLA P06280 1/20 0.33
CYP3A4 P08684 1/20 0.33
NOTUM Q6P988 1/20 0.33
ALDH1A1 P00352 1/20 0.32
MAPT P10636 1/20 0.32
MAPK1 P28482 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
IDO1 P14902 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8632301 0.84 GAA (0.44) BRD4GLAALDH1A1MAPTMAPK1
SCHEMBL8630595 0.82 CES2 (0.38) BRD4CES2CES1HDAC6
SCHEMBL8632971 0.82 NOTUM (0.38) P2RX7GLANOTUMMAPTSMN1; SMN2
SCHEMBL8634802 0.81 ALDH1A1 (0.38) P2RX7GLANOTUMALDH1A1MAPT
SCHEMBL8636185 0.74 BRD4 (0.43) BRD4CYP3A4NOTUMALDH1A1MAPT
SCHEMBL8634779 0.72 KMT2A (0.38) GLAALDH1A1MAPTMAPK1SMN1; SMN2
SCHEMBL30057873 0.71 CES2 (0.52) BRD4CES2CES1CYP3A4ALDH1A1
SCHEMBL1902230 0.71 CES2 (0.52) BRD4CES2CES1CYP3A4ALDH1A1
SCHEMBL8633722 0.70 BRD4 (0.41) BRD4CYP3A4NOTUMALDH1A1MAPT
SCHEMBL8633856 0.70 BRD4 (0.40) BRD4CES2CES1HDAC4HDAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1047169-C (1-phenyl-1-heterocyclyl) methanol and (1-phenyl-1-heterocyclyl) methylamine derivatives ASTRA AB (SE) 1999-12-08 CN claimed
US-5712299-A TREATMENT OF NEURODEGENERATIVE DISORDERS ASTRA AKTIEBOLAG (SE) 1998-01-27 US claimed
CN-1126991-A Novel (1-phenyl-1-heterocyclyl) methanol and (1-phenyl-1-heterocyclyl) methylamine derivatives ASTRA AB (SE) 1996-07-17 CN claimed
EP-0707574-A1 NOVEL (1-PHENYL-1-HETEROCYCLYL)METHANOL AND (1-PHENYL-1-HETEROCYCLYL)METHYLAMINE DERIVATIVES Astra Aktiebolag (SE) 1996-04-24 EP claimed
WO-1995001968-A1 NOVEL (1-PHENYL-1-HETEROCYCLYL)METHANOL AND (1-PHENYL-1-HETEROCYCLYL)METHYLAMINE DERIVATIVES ASTRA AKTIEBOLAG (SE) 1995-01-19 WO claimed
CN-1047169-C (1-phenyl-1-heterocyclyl) methanol and (1-phenyl-1-heterocyclyl) methylamine derivatives ASTRA AB (SE) 1999-12-08 CN disclosed
US-5712299-A TREATMENT OF NEURODEGENERATIVE DISORDERS ASTRA AKTIEBOLAG (SE) 1998-01-27 US disclosed
CN-1126991-A Novel (1-phenyl-1-heterocyclyl) methanol and (1-phenyl-1-heterocyclyl) methylamine derivatives ASTRA AB (SE) 1996-07-17 CN disclosed
EP-0707574-A1 NOVEL (1-PHENYL-1-HETEROCYCLYL)METHANOL AND (1-PHENYL-1-HETEROCYCLYL)METHYLAMINE DERIVATIVES Astra Aktiebolag (SE) 1996-04-24 EP disclosed
WO-1995001968-A1 NOVEL (1-PHENYL-1-HETEROCYCLYL)METHANOL AND (1-PHENYL-1-HETEROCYCLYL)METHYLAMINE DERIVATIVES ASTRA AKTIEBOLAG (SE) 1995-01-19 WO disclosed